Skip to main content

Latest collections open to submissions

Cancer-associated fibroblasts

Guest edited by Lukas Lacina and Karel Smetana

Cancer vaccines

Guest edited by Leonardo O. Reis and Chunlin Ou

Quality of life and supportive care in cancer

Guest edited by Eileen Shinn and Christina Signorelli

Editors' Picks

New Content ItemIt’s about time: mitigating cancer-related cognitive impairments through findings from computational models of the Wisconsin Card Sorting Task

New Content ItemAT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma

New Content ItemInfluence of cryoablation versus operation on circulating lymphocyte subsets in patients with early-stage renal cell carcinoma

New Content ItemAntitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma

Trending BMC Cancer Articles

Click here to view which Articles have been shared most in the last month!

Articles

Targeted Therapies for Cancer
Guest edited by Prof. Min Li and Dr. Yanis Boumber
Open for submissions

Microbiome and Cancer
Guest edited by Christopher Staley, Jacques Ravel, Sean Devlin
Open for submissions

Cross journal collection: Advances in CAR-T immunotherapy
Guest edited by Profs Marko Radic, Djordje Atanackovic and Tim Luetkens
Collection published: 30 June 2020

Cross journal collection: Precision Oncology
Collection published: 28 August 2019

Browse all BMC Cancer collection contributions


Aims and Scope


BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions in broad areas of cancer research including molecular and cellular biology, genetics, epidemiology, and clinical trials. Learn more about our scope here

Become an Editorial Board Member

We are recruiting new Editorial Board Members.

Read More

New Content Item (1)

BMC Cancer is celebrating its 20th anniversary! 

Since launching in 2001, we've become established as the largest open access oncology journal in our field. We're proud of our history of making cancer research and methods available to all. We have been looking back at our achievements and highlighted some of the most influential research published in the journal over the past two decades. 

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.4
    5-year Journal Impact Factor: 3.8
    Source Normalized Impact per Paper (SNIP): 0.944
    SCImago Journal Rank (SJR): 1.087

    Speed 2023
    Submission to first editorial decision (median days): 12
    Submission to acceptance (median days): 150

    Usage 2023
    Downloads: 7,974,312
    Altmetric mentions: 3,975

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal